From: Epanorin, a lichen secondary metabolite, inhibits proliferation of MCF-7 breast cancer cells
Treatment | Number of histidine + revertants | |||||||
---|---|---|---|---|---|---|---|---|
TA98 | TA100 | TA102 | TA104 | |||||
S9− | S9+ | S9− | S9+ | S9− | S9+ | S9− | S9+ | |
Spontaneous revertions | 30 ± 2 | 22 ± 4 | 40 ± 7 | 38 ± 6 | 345 ± 43 | 328 ± 28 | 315 ± 23 | 365 ± 48 |
DMSO | 26 ± 6 | 24 ± 3 | 42 ± 3 | 39 ± 7 | 305 ± 32 | 324 ± 35 | 363 ± 32 | 321 ± 24 |
Standard mutagensa | 87 ± 14 | 968 ± 192 | 320 ± 66 | 790 ± 59 | 1416 ± 34 | 4848 ± 113 | 2069 ± 125 | 4625 ± 167 |
E 0.125 µg/plate | 26 ± 6 | 29 ± 2 | 52 ± 5 | 56 ± 6 | 352 ± 25 | 359 ± 9 | 384 ± 46 | 361 ± 52 |
E 12.5 µg/plate | 26 ± 4 | 27 ± 1 | 50 ± 4 | 40 ± 3 | 306 ± 19 | 352 ± 21 | 325 ± 41 | 374 ± 28 |
E 125 µg/plate | 22 ± 6 | 22 ± 2 | 47 ± 9 | 40 ± 6 | 296 ± 47 | 340 ± 21 | 359 ± 36 | 346 ± 44 |